STOCK TITAN

Amgen (AMGN) investor files to sell 2,000 shares valued at $828,420

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A holder of Amgen (AMGN) common stock filed a notice of intent to sell up to 2,000 shares through Fidelity Brokerage Services LLC on NASDAQ, with an indicated aggregate market value of about $828,420. The shares were originally received as stock awards from the issuer on multiple compensation grant dates in 2022 and 2023.

Positive

  • None.

Negative

  • None.
Shares to be sold 2,000 shares Common stock listed for proposed sale in the Form 144
Aggregate market value $828,420.00 Indicated value of the 2,000 common shares to be sold
CUSIP 540632005 CUSIP associated with the Amgen common stock in the filing
Proposed sale date 08/11/2026 Date from which the filer may sell the shares on NASDAQ
Stock award 03/18/2022 603 shares Common stock granted as a stock award for compensation
Stock award 03/17/2023 452 shares Common stock granted as a stock award for compensation
Form 144 regulatory
"144: Securities Information Common | Fidelity Brokerage Services LLC"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Securities To Be Sold regulatory
"144: Securities To Be Sold Common | 03/18/2022 | Stock award"
Stock award financial
"Common | 03/18/2022 | Stock award | Issuer |"
compensation financial
"603 | 03/18/2022 | compensation Common | 04/27/2022"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What does this Form 144 filing for AMGN disclose?

It discloses a holder’s intent to sell up to 2,000 shares of Amgen (AMGN) common stock. The proposed sale will be executed through Fidelity Brokerage Services LLC on NASDAQ and is based on an aggregate market value of about $828,420.

How many AMGN shares are planned for sale and at what value?

The filing contemplates the sale of 2,000 shares of Amgen common stock. The shares are associated with an indicated aggregate market value of roughly $828,420, reflecting the filer’s estimate at the time of the notice of proposed sale.

When is the proposed sale of AMGN shares expected under this notice?

The notice lists a proposed sale date of August 11, 2026. This date reflects when the filer may begin selling the 2,000 Amgen shares on NASDAQ through Fidelity Brokerage Services LLC, subject to market conditions and applicable securities regulations.

How were the AMGN shares in this Form 144 originally acquired?

The shares were acquired through multiple stock awards from the issuer as compensation. Grants include 603 shares on March 18, 2022, 452 shares on March 17, 2023, and several smaller awards across 2022 and 2023, all described as compensation.

Which broker and market are involved in the planned AMGN share sale?

The planned sale will be handled by Fidelity Brokerage Services LLC and executed on NASDAQ. The Form 144 specifies Fidelity’s Boston address and identifies NASDAQ as the trading market for the proposed disposition of the 2,000 Amgen common shares.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature